Larvol Delta - Amphista-Therapeutics-announces-FDA-clearance-of-IND-application-for-AMX883-its-lead-Targeted-Glue-degrader-for-acute-myeloid-leukaemia

AMX-883 - Amphista Therap

https://www.globenewswire.com/news-release/2026/06/08/3307798/0/en/Amphista-Therapeutics-announces-FDA-clearance-of-IND-application-for-AMX-883-its-lead-Targeted-Glue-degrader-for-acute-myeloid-leukaemia.html

Jun 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next